TG Therapeutics

TG Therapeutics

TGTX· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -1.0% in FY2025

Michael S. Weiss is the CEO of TG Therapeutics and was paid $25.6M in FY2025 (Dec), up 36%.

Pay$100 in the stock at the end of FY20 → $57
CEO pay is from each TG Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives2

See all
  1. 1Michael S. WeissFY2025
  2. 2Sean A. PowerFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

TG Therapeutics paid its 2 named executives $29.3M in total in FY2025 (Dec). CEO Michael S. Weiss was paid $25.6M of that.

Name
Michael S. WeissChief Executive Officer and President
Sean A. PowerChief Financial Officer, Treasurer and Corporate Secretary

of each named executive, from the Summary Compensation Table of each proxy.

Peers17

See all

The FY2025 (Dec) proxy of TG Therapeutics names 17 peer companies for pay. Among TG Therapeutics and these peers, CEO pay was the highest of 10 and total shareholder return was 9th highest of 10.

1st highest of 10in TG Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:

$6.9M$25.6M

9th highest of 10in TG Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:

$17$524

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Activity

Filings6

See all
Proxy statementDEF 14AApr 30, 2026FY2025
Annual report10-KFeb 27, 2026FY2025
Proxy statementDEF 14AApr 30, 2025FY2024
Annual report10-KMar 3, 2025FY2024
Proxy statementDEF 14AApr 29, 2024FY2023
Annual report10-KFeb 29, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data